Litcius/Paper detail

Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies

George S. Laszlo, Johnnie J. Orozco, Allie R. Kehret, Margaret C. Lunn-Halbert, Jenny Huo, Donald K. Hamlin, D. Scott Wilbur, Shannon L. Dexter, Melissa L. Comstock, Shyril O’Steen, Brenda M. Sandmaier, Damian J. Green, Roland B. Walter

2022Leukemia22 citationsDOIOpen Access PDF

Topics & Concepts

RadioimmunotherapyInterleukin-3 receptorLeukemiaCancer researchMonoclonal antibodyMedicineStem cellImmunologyBiologyAntibodyCell biologyRadiopharmaceutical Chemistry and ApplicationsNeuroblastoma Research and TreatmentsLung Cancer Research Studies
Development of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies | Litcius